Prostate High Dose-Rate Brachytherapy As Monotherapy for Low and Intermediate-Risk Prostate Cancer: Efficacy Results from a Randomized Phase II Clinical Trial of One Fraction of 19 Gy or Two Fractions of 13.5 Gy: A 9-Year Update
Radiotherapy and Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要